Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Am J Hum Genet ; 98(4): 667-79, 2016 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-27018473

RESUMO

Genetic studies of autism spectrum disorder (ASD) have established that de novo duplications and deletions contribute to risk. However, ascertainment of structural variants (SVs) has been restricted by the coarse resolution of current approaches. By applying a custom pipeline for SV discovery, genotyping, and de novo assembly to genome sequencing of 235 subjects (71 affected individuals, 26 healthy siblings, and their parents), we compiled an atlas of 29,719 SV loci (5,213/genome), comprising 11 different classes. We found a high diversity of de novo mutations, the majority of which were undetectable by previous methods. In addition, we observed complex mutation clusters where combinations of de novo SVs, nucleotide substitutions, and indels occurred as a single event. We estimate a high rate of structural mutation in humans (20%) and propose that genetic risk for ASD is attributable to an elevated frequency of gene-disrupting de novo SVs, but not an elevated rate of genome rearrangement.


Assuntos
Transtorno do Espectro Autista/genética , Deleção de Genes , Duplicação Gênica , Alelos , Sequência de Aminoácidos , Sequência de Bases , Estudos de Casos e Controles , Criança , Variações do Número de Cópias de DNA , Feminino , Frequência do Gene , Rearranjo Gênico , Loci Gênicos , Genoma Humano , Técnicas de Genotipagem , Humanos , Mutação INDEL , Masculino , Análise em Microsséries , Dados de Sequência Molecular , Linhagem , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
2.
Proc Natl Acad Sci U S A ; 110(1): E15-22, 2013 Jan 02.
Artigo em Inglês | MEDLINE | ID: mdl-23236148

RESUMO

The idea of targeted therapy, whereby drug or protein molecules are delivered to specific cells, is a compelling approach to treating disease. Immunotoxins are one such targeted therapeutic, consisting of an antibody domain for binding target cells and molecules of a toxin that inhibits the proliferation of the targeted cell. One major hurdle preventing these therapies from reaching the market has been the lack of a suitable production platform that allows the cost-effective production of these highly complex molecules. The chloroplast of the green alga Chlamydomonas reinhardtii has been shown to contain the machinery necessary to fold and assemble complex eukaryotic proteins. However, the translational apparatus of chloroplasts resembles that of a prokaryote, allowing them to accumulate eukaryotic toxins that otherwise would kill a eukaryotic host. Here we show expression and accumulation of monomeric and dimeric immunotoxin proteins in algal chloroplasts. These fusion proteins contain an antibody domain targeting CD22, a B-cell surface epitope, and the enzymatic domain of exotoxin A from Pseudomonas aeruginosa. We demonstrated that algal-produced immunotoxins accumulate as soluble and enzymatically active proteins that bind target B cells and efficiently kill them in vitro. We also show that treatment with either the mono- or dimeric immunotoxins significantly prolongs the survival of mice with implanted human B-cell tumors.


Assuntos
Chlamydomonas reinhardtii/metabolismo , Cloroplastos/metabolismo , Imunotoxinas/isolamento & purificação , Imunotoxinas/farmacologia , Linfoma/tratamento farmacológico , Engenharia de Proteínas/métodos , Animais , Western Blotting , Cromatografia em Gel , Proteínas de Ligação a DNA/genética , Eletroforese em Gel de Poliacrilamida , Feminino , Citometria de Fluxo , Vetores Genéticos/genética , Humanos , Camundongos , Camundongos Knockout , Organismos Geneticamente Modificados , Proteínas Recombinantes/metabolismo , Transformação Genética , Transplante Heterólogo
3.
Plant Biotechnol J ; 13(1): 117-24, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25229405

RESUMO

We have produced three antitoxins consisting of the variable domains of camelid heavy chain-only antibodies (VH H) by expressing the genes in the chloroplast of green algae. These antitoxins accumulate as soluble proteins capable of binding and neutralizing botulinum neurotoxin. Furthermore, they accumulate at up to 5% total soluble protein, sufficient expression to easily produce these antitoxins at scale from algae. The genes for the three different antitoxins were transformed into Chlamydomonas reinhardtii chloroplasts and their products purified from algae lysates and assayed for in vitro biological activity using toxin protection assays. The produced antibody domains bind to botulinum neurotoxin serotype A (BoNT/A) with similar affinities as camelid antibodies produced in Escherichia coli, and they are similarly able to protect primary rat neurons from intoxication by BoNT/A. Furthermore, the camelid antibodies were produced in algae without the use of solubilization tags commonly employed in E. coli. These camelid antibody domains are potent antigen-binding proteins and the heterodimer fusion protein containing two VH H domains was capable of neutralizing BoNT/A at near equimolar concentrations with the toxin. Intact antibody domains were detected in the gastrointestinal (GI) tract of mice treated orally with antitoxin-producing microalgae. These findings support the use of orally delivered antitoxins produced in green algae as a novel treatment for botulism.


Assuntos
Antitoxinas/imunologia , Toxinas Botulínicas/imunologia , Camelídeos Americanos/imunologia , Chlamydomonas reinhardtii/imunologia , Cloroplastos/metabolismo , Cadeias Pesadas de Imunoglobulinas/imunologia , Região Variável de Imunoglobulina/imunologia , Animais , Anticorpos Neutralizantes/imunologia , Antígenos/imunologia , Sobrevivência Celular , Chlamydomonas reinhardtii/genética , Vetores Genéticos/metabolismo , Camundongos , Reação em Cadeia da Polimerase , Proteínas Recombinantes/metabolismo , Anticorpos de Domínio Único/imunologia , Transformação Genética , Transgenes
4.
Plant J ; 74(4): 545-56, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23521393

RESUMO

Fluorescent proteins (FPs) have become essential tools for a growing number of fields in biology. However, such tools have not been widely adopted for use in microalgal research. The aim of this study was to express and compare six FPs (blue mTagBFP, cyan mCerulean, green CrGFP, yellow Venus, orange tdTomato and red mCherry) in the popular model microalga Chlamydomonas reinhardtii. To circumvent the transgene silencing that often occurs in C. reinhardtii, the FPs were expressed from the nuclear genome as transcriptional fusions with the sh-ble antibiotic resistance gene, with the foot and mouth disease virus 2A self-cleaving sequence placed between the coding sequences. All ble-2A-FPs tested are well-expressed and efficiently processed to yield mature, unfused FPs that localize throughout the cytoplasm. The fluorescence signals of each FP were detectable in whole cells by fluorescence microplate reader analysis, live-cell fluorescence microscopy, and flow cytometry. Furthermore, we report a comparative analysis of fluorescence levels relative to auto-fluorescence for the chosen FPs. Finally, we demonstrate that the ble-2A expression vector may be used to fluorescently label an endogenous protein (α-tubulin). We show that the mCerulean-α-tubulin fusion protein localizes to the cytoskeleton and flagella, as expected, and that cells containing this fusion protein had normal cellular function. Overall, our results indicate that, by use of the ble-2A nuclear expression construct, a wide array of FP tools and technologies may be applied to microalgal research, opening up many possibilities for microalgal biology and biotechnology.


Assuntos
Proteínas de Bactérias/genética , Chlamydomonas reinhardtii/genética , Vetores Genéticos/genética , Proteínas Luminescentes/genética , Proteínas Virais/genética , Proteínas de Algas/genética , Proteínas de Algas/metabolismo , Proteínas de Bactérias/metabolismo , Núcleo Celular/genética , Núcleo Celular/metabolismo , Chlamydomonas reinhardtii/citologia , Chlamydomonas reinhardtii/metabolismo , Citoplasma/metabolismo , Citoesqueleto/metabolismo , Flagelos/metabolismo , Citometria de Fluxo , Expressão Gênica , Genes Reporter , Immunoblotting , Proteínas Luminescentes/metabolismo , Microscopia de Fluorescência , Proteínas Recombinantes de Fusão , Transformação Genética , Transgenes , Tubulina (Proteína)/genética , Tubulina (Proteína)/metabolismo , Proteínas Virais/metabolismo
5.
PLoS One ; 9(4): e94028, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24710110

RESUMO

Transgenic microalgae have the potential to impact many diverse biotechnological industries including energy, human and animal nutrition, pharmaceuticals, health and beauty, and specialty chemicals. However, major obstacles to sophisticated genetic and metabolic engineering in algae have been the lack of well-characterized transformation vectors to direct engineered gene products to specific subcellular locations, and the inability to robustly express multiple nuclear-encoded transgenes within a single cell. Here we validate a set of genetic tools that enable protein targeting to distinct subcellular locations, and present two complementary methods for multigene engineering in the eukaryotic green microalga Chlamydomonas reinhardtii. The tools described here will enable advanced metabolic and genetic engineering to promote microalgae biotechnology and product commercialization.


Assuntos
Biotecnologia/métodos , Chlamydomonas reinhardtii/genética , Engenharia Genética/métodos , Melhoramento Genético , Transgenes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA